Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
Oestrogen receptor alpha (ER; gene symbol ESR1) is the most important prognostic and treatment‐predictive biomarker in breast cancer. Drugs targeting oestrogen and ER for endocrine therapy of breast cancer include aromatase inhibitors, the selective ER modulator tamoxifen and the selective ER degrad...
Saved in:
| Main Authors: | Juliane Albrecht, Mirjam Müller, Völundur Hafstað, Kamila Kaminska, Johan Vallon‐Christersson, Gabriella Honeth, Helena Persson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.13713 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oestrogen Receptor Alpha in Myocyte Maintains Muscle Regeneration in Duchenne Muscular Dystrophy
by: Xiaofei Huang, et al.
Published: (2025-04-01) -
“Four years of remission with fulvestrant monotherapy in advanced endometrioid adenocarcinoma of the endometrium Harboring an ESR1 Mutation: A case Report”
by: João Felipe Feldmann, et al.
Published: (2025-06-01) -
Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
by: Anca Dragomirescu,, et al.
Published: (2008-12-01) -
Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
by: Keenan L. Flynn, et al.
Published: (2024-11-01) -
High Dose Oestrogen in Life Threatening Obscure Gastrointestinal Bleeding
by: Meng Kang Tee, et al.
Published: (2022-09-01)